Plain-English translation of NCT06366724 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
United States
Sponsor
Brigham and Women's Hospital
Collaborators
Open Medicine Foundation
Enrollment target
~160 participants
Started
September 2024
Primary completion
September 2026
Age range
18 Years – 70 Years
Last updated on clinicaltrials.gov in October 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Research Coordinator
Massachusetts General Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.